These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23600092)

  • 21. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
    Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
    JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
    Osazuwa-Peters N
    Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
    Knudtson M; Tiso S; Phillips S
    Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
    Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
    Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV vaccination - a paradigm shift in public health.
    May J
    Aust Fam Physician; 2007 Mar; 36(3):106-11. PubMed ID: 17339969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The first vaccine against cancer: the human papillomavirus vaccine].
    Bősze P
    Orv Hetil; 2013 Apr; 154(16):603-18. PubMed ID: 23587540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
    Broomall EM; Reynolds SM; Jacobson RM
    Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of HPV After Introduction of the Vaccination Program in the United States.
    Markowitz LE; Liu G; Hariri S; Steinau M; Dunne EF; Unger ER
    Pediatrics; 2016 Mar; 137(3):e20151968. PubMed ID: 26908697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Human papillomavirus vaccine. Statement of the Advisory Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008].
    Abarca K; Valenzuela MT; Vergara R; Luchsinger V; Muñoz A; Jiménez de la J J; Ripoll E; O'Ryan M;
    Rev Med Chil; 2008 Nov; 136(11):1485-92. PubMed ID: 19301782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canadian school-based HPV vaccine programs and policy considerations.
    Shapiro GK; Guichon J; Kelaher M
    Vaccine; 2017 Oct; 35(42):5700-5707. PubMed ID: 28893472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus vaccine uptake among males 11-26 years in United States: findings from the National Health and Nutrition Examination Survey, 2011-2012.
    Pierre-Victor D; Mukherjee S; Bahelah R; Madhivanan P
    Vaccine; 2014 Nov; 32(49):6655-8. PubMed ID: 25446825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Prevention Begins in Middle School: The Personal Advantages of HPV Immunization in Males.
    Gordon J; Bail J
    NASN Sch Nurse; 2023 May; 38(3):114-120. PubMed ID: 36691362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.
    McIntosh J; Sturpe DA; Khanna N
    J Am Pharm Assoc (2003); 2008; 48(1):e1-13; quiz e14-7. PubMed ID: 18192123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends and predictors of HPV vaccination among U.S. College women and men.
    Thompson EL; Vamos CA; Vázquez-Otero C; Logan R; Griner S; Daley EM
    Prev Med; 2016 May; 86():92-8. PubMed ID: 26868093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention strategies against human papillomavirus in males.
    Garland SM
    Gynecol Oncol; 2010 May; 117(2 Suppl):S20-5. PubMed ID: 20138347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early lessons learned from extramural school programs that offer HPV vaccine.
    Hayes KA; Entzel P; Berger W; Caskey RN; Shlay JC; Stubbs BW; Smith JS; Brewer NT
    J Sch Health; 2013 Feb; 83(2):119-26. PubMed ID: 23331272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introducing human papillomavirus vaccines into the health system in South Africa.
    Botha MH; Dochez C
    Vaccine; 2012 Sep; 30 Suppl 3():C28-34. PubMed ID: 22939017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPV knowledge and vaccination rates in college-aged males: Implications for practice.
    McCutcheon T; Schaar G
    Nurse Pract; 2017 Jan; 42(1):49-53. PubMed ID: 28002145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Papillomavirus Vaccination Coverage Among Female Adolescents in Managed Care Plans - United States, 2013.
    Ng J; Ye F; Roth L; Sobel K; Byron S; Barton M; Lindley M; Stokley S
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(42):1185-9. PubMed ID: 26513219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Committee Opinion Summary No. 641: Human Papillomavirus Vaccination.
    Obstet Gynecol; 2015 Sep; 126(3):693. PubMed ID: 26287785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.